go back

Lisocabtagene Maraleucel (Breyanzi) CAR-T Therapy

Kentucky rates for HCPCS Q2054

Lisocabtagene maraleucel, up to 110 million autologous anti-CD19 CAR-positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Rates data updated July 2026.

Facilitymedian $660,693 · 10th–90th $562,341$660,6930%50%10th$660,693Professionalmedian $562,341 · 10th–90th $562,341$794,3280%50%90th$562,341$0.0$0.5$10.0$200.0$5.0K$100.0K$2.0M

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$562,341.33
Median
$562,341.33
Typical High
$954,992.59
Aetna
Setting
Professional
Modifier
Global
Typical Low
$562,341.33
Median
$562,341.33
Typical High
$794,328.23
Anthem BCBS
Setting
Facility
Modifier
Global
Typical Low
$0.03
Median
$660,693.45
Typical High
$660,693.45
Anthem BCBS
Setting
Professional
Modifier
Global
Typical Low
$562,341.33
Median
$562,341.33
Typical High
$562,341.33
CareSource
Setting
Facility
Modifier
Global
Typical Low
$562,341.33
Median
$562,341.33
Typical High
$891,250.94
CareSource
Setting
Professional
Modifier
Global
Typical Low
$562,341.33
Median
$588,843.66
Typical High
$794,328.23
Molina
Setting
Professional
Modifier
Global
Typical Low
$5,011.87
Median
$5,011.87
Typical High
$5,011.87
United
Setting
Facility
Modifier
Global
Typical Low
$562,341.33
Median
$562,341.33
Typical High
$562,341.33
United
Setting
Professional
Modifier
Global
Typical Low
$346,736.85
Median
$512,861.38
Typical High
$616,595.00